WGS
GeneDx Holdings Corp.
NASDAQ: WGS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$40.77
+0.67% today
Updated 2026-05-08
Market cap
$1.20B
P/E ratio
—
P/S ratio
2.72x
EPS (TTM)
$-2.66
Dividend yield
—
52W range
$32 – $171
Volume
1.1M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+6.5
Quality
B2.0
Profitability
F4.0
Valuation
C6/9
Piotroski F-Score
Moderate
-2.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$85.89
+110.67%
12-Month target
—
—
Intrinsic (DCF)
$59.37
Margin of safety
-54.02%
1 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 17.40% QoQ
+ Debt/equity 0.39x — low leverage
Risks
- Altman Z -2.39 — distress zone
- Thin margins at -17.60%
- Negative free cash flow $-38.86M
- 54.02% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $234.69M | $202.57M | $305.45M | $427.54M | $442.68M |
| Net income | $-548.98M | $-175.77M | $-52.29M | $-21.02M | $-63.32M |
| EPS | — | — | — | — | $-2.66 |
| Free cash flow | $-333.48M | $-185.86M | $-33.99M | $14.26M | $-38.86M |
| Profit margin | -233.91% | -86.77% | -17.12% | -4.92% | -17.60% |
Peer comparison
Smart narrative
GeneDx Holdings Corp. trades at $40.77. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of -2.39, it sits in the distress. TTM revenue stands at $442.68M. with profit margins at -17.60%. Our DCF model estimates intrinsic value at $59.37.
Frequently asked questions
What is GeneDx Holdings Corp.'s stock price?
GeneDx Holdings Corp. (WGS) trades at $40.77.
Is GeneDx Holdings Corp. overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell). DCF value $59.37.
What is the price target of GeneDx Holdings Corp. (WGS)?
The analyst target price is $85.89, representing +110.7% upside from the current price of $40.77.
What is the intrinsic value of GeneDx Holdings Corp. (WGS)?
Based on our DCF model, intrinsic value is $59.37, a -54.0% margin of safety versus $40.77.
What is GeneDx Holdings Corp.'s revenue?
TTM revenue is $442.68M.
Piotroski F-Score?
6/9 — moderate financial health.
Altman Z-Score?
-2.39 — distress.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.72x
ROE-30.40%
Beta2.07
50D MA$68.41
200D MA$108.37
Shares out0.03B
Float0.02B
Short ratio—
Avg volume1.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—